Eriko Shikata

668 total citations
5 papers, 535 citations indexed

About

Eriko Shikata is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eriko Shikata has authored 5 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eriko Shikata's work include Drug Transport and Resistance Mechanisms (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and Vitamin K Research Studies (1 paper). Eriko Shikata is often cited by papers focused on Drug Transport and Resistance Mechanisms (2 papers), Amino Acid Enzymes and Metabolism (1 paper) and Vitamin K Research Studies (1 paper). Eriko Shikata collaborates with scholars based in Japan. Eriko Shikata's co-authors include Ichiro Ieiri, Kenji Otsubo, Hiroshi Takane, Tadasu Ikeda, Chiaki Shigemasa, Shun Higuchi, Kazuko Inoue, Tomoko Koide, Shigetsugu Ohgi and Shingo Ishiguro and has published in prestigious journals such as Blood, American Journal of Physiology-Cell Physiology and Pharmacogenomics.

In The Last Decade

Eriko Shikata

5 papers receiving 520 citations

Peers

Eriko Shikata
Comparison fields: 5 of 74
  • Molecular Biology 235
  • Endocrinology, Diabetes and Metabolism 190
  • Oncology 160
  • Pharmacology 146
  • Cell Biology 84
Replace Dagmara Mohuczy with:
Dagmara Mohuczy United States
H Oftebro Norway
Michel Kaufmann Switzerland
C. E. Watson United States
Makoto Osabe Japan
Shaheen Khadem United States
Kai E. Penttilä Finland
Hiroaki Yasumo Japan
Pnina Scherzer Israel
Marie José Vilarem France
Dagmara Mohuczy United States View profile →
Citations per field, relative to Eriko Shikata
Eriko Shikata · 1×
Citations per year, relative to Eriko Shikata
Eriko Shikata · 1×

Countries citing papers authored by Eriko Shikata

Since Specialization
Citations

This map shows the geographic impact of Eriko Shikata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Shikata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Shikata more than expected).

Fields of papers citing papers by Eriko Shikata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Shikata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Shikata. The network helps show where Eriko Shikata may publish in the future.

Co-authorship network of co-authors of Eriko Shikata

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Shikata. A scholar is included among the top collaborators of Eriko Shikata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Shikata. Eriko Shikata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026